Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2001-11-13
2002-10-08
Jarvis, William R. A. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S787000, C514S966000
Reexamination Certificate
active
06462083
ABSTRACT:
TECHNICAL FIELD
This invention relates to a suppository base comprised of erucic acid and beeswax which provides enhanced chemical stability, moldability, and shelf-life to the suppository product and the medicine contained therein.
BACKGROUND OF THE INVENTION
Suppositories are solid dosage forms of medicine intended for administration via the rectum, vagina, or urethra. Suppositories are useful drug delivery systems in many situations where the patient cannot receive medicine orally, intravenously, or by injection (such as when a patient is vomiting, experiencing seizures, or has an obstruction of the upper gastrointestinal tract); or where only a local effect is needed (such as when a patient has a lower gastrointestinal malady or vaginal infection); or where the medicine is not orally effective and an alternate route of administration is necessary (such as when medicine exhibits first-pass metabolism).
Suppositories are compounded so as to melt, soften, or dissolve in the body cavity (around 98.6° F.) thereby releasing the medication contained therein. Suppository bases should be stable, nonirritating, chemically inert, and physiologically inert. Many commercially available suppositories contain oily or fatty base materials, such as cocoa butter, coconut oil, palm kernel oil, and palm oil, which often melt or deform at room temperature necessitating cool storage or other storage limitations. U.S. Pat. No. 4,837,214 to Tanaka et al. describes a suppository base comprised of 80 to 99 percent by weight of a lauric-type fat having a hydroxyl value of 20 or smaller and containing glycerides of fatty acids having 8 to 18 carbon atoms combined with 1 to 20 percent by weight diglycerides of fatty acids (which erucic acid is an example of). The shelf life of these type of suppositories is limited due to degradation. Other suppository bases contain alcohols, surfactants, and the like which raise the melting temperature but also can lead to poor absorption of the medicine and side effects due to irritation of the local mucous membranes (see for example, U.S. Pat. No. 6,099,853 to Hartelendy et al., U.S. Pat. No. 4,999,342 to Ahmad et al., and U.S. Pat. No. 4,765,978 to Abidi et al.).
The present invention provides one solution to the limitations of the currently available suppository bases as is discussed in the disclosure that follows. Here a suppository base comprised of erucic acid and beeswax provides enhanced chemical stability, moldability, and shelf-life. The composition described in this invention is further expected to enhance the delivery of medicine by increasing localized blood flow thus improving the absorption of medicine contained therein.
SUMMARY OF THE INVENTION
The present invention is directed to a suppository base comprised of erucic acid. Another embodiment of the suppository base is comprised of erucic acid and beeswax. The amount of erucic acid in the composition can range from about 90 to about 99 percent by weight and the amount of beeswax present in the composition can range from about 1 to about 10 percent by weight. The most preferred base composition contains about 10 percent by weight beeswax and about 90 percent by weight erucic acid. Additives such as colorants, preservatives, stabilizers, solvents, and fragrances are also contemplated.
DETAILED DESCRIPTION OF THE INVENTION
Erucic acid or (Z)-13-Docosenoic acid (&Dgr;
13
cis-decosenoic acid; C
22
H
42
O
2
) is a monoethenoid acid found in the seed fats of Cruciferae and Tropaeolaccae family of plants. It constitutes about 50 percent of the total fatty acids in rapeseed, mustard, and wallflower seeds and about 80 percent of the total fatty acids in nasturtium seeds (K. S. Markley, Fatty Acids Part I, Interscience, New York, Second Ed., 1960)
Erucic acid is prepared by the alkaline hydrolysis of rapeseed oil and further refined by fractional precipitation, crystallization, or acid soap crystallization. Erucic acid can be found in cooking oils, mustards, industrial lubricants, plastic materials, hair care products, and fabric softeners. Erucic acid is thought to be a vasodilator and has been shown to enhance blood flow to the site of administration by laser Doppler imaging.
Preferably, the present inventive suppository base composition is comprised of erucic acid to which beeswax can be added. More preferably, the present invention contains about 90 to about 99 percent by weight erucic acid and beeswax in an amount of about 1 to about 10 percent by weight. Most preferably, the suppository base comprises about 10 percent by weight beeswax and about 90 percent by weight erucic acid. Another embodiment further comprises a colorant, a preservative, a stabilizer, a solvent, a fragrance, or mixtures thereof.
REFERENCES:
patent: 4837214 (1989-06-01), Tanaka et al.
patent: 5364879 (1994-11-01), Herman
patent: 5405608 (1995-04-01), Xu
patent: 6096338 (2000-08-01), Lacy et al.
patent: 6365198 (2002-04-01), Niazi
Jarvis William R. A.
Kim Vickie
Welsh & Katz Ltd.
LandOfFree
Suppository base does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suppository base, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppository base will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2993483